Edition:
United States

IBEX Technologies Inc (IBT.V)

IBT.V on TSX Venture Exchange

0.15CAD
24 Feb 2017
Change (% chg)

$-0.00 (-3.23%)
Prev Close
$0.16
Open
$0.15
Day's High
$0.15
Day's Low
$0.15
Volume
4,500
Avg. Vol
16,830
52-wk High
$0.17
52-wk Low
$0.08

IBT.V

Chart for IBT.V

About

IBEX Technologies Inc., through its subsidiaries, IBEX Pharmaceuticals Inc. and BioResearch Products Inc., manufactures and markets enzymes for biomedical use. The Company also manufactures and markets a series of arthritis assays, which enable the study of both the synthesis and degradation of cartilage components. It operates... (more)
No analyst recommendations are available for IBT.V.

Overall

Beta: 0.04
Market Cap(Mil.): $3.71
Shares Outstanding(Mil.): 24.70
Dividend: --
Yield (%): --

Financials

  IBT.V Industry Sector
P/E (TTM): -- 44.08 29.63
EPS (TTM): -0.00 -- --
ROI: -0.99 -3.35 12.96
ROE: -1.21 5.80 14.11

BRIEF-Ibex reports results for the year ended July 31

* Believes it has sufficient funds to meet obligations, planned expenditures for ensuing twelve months as they fall due

Nov 04 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.